Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
Intestinal Behçet’s disease is a rare, immune-mediated chronic intestinal inflammatory disease; therefore, clinical trials to optimize the management and treatment of patients are scarce. Moreover, intestinal Behçet’s disease is difficult to treat and often requires surgery because of the failure of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Gastroenterology Council for Gut and Liver
2018-11-01
|
| Series: | Gut and Liver |
| Subjects: | |
| Online Access: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl17462 |